EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinicopathological Factors Predisposing to No. 12a Lymph Node Metastasis in Gastric Cancer: A Prospective Cohort Analysis

Amirmohsen Jalaeefar iD, Habibollah Mahmoodzadeh iD, Mohammad Shirkhoda iD, Ramesh Omranipour iD, Seyed Rouhollah Miri iD, Narjes Mohammadzadeh iD, Arshia Zardoui iD, Amirsina Sharifi iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Amirmohsen Jalaeefar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Subdivision of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrectomy, Lymph Node Excision, Lymph Nodes. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The current standard surgical procedure for gastric cancer (GC) is gastrectomy and D2 lymphadenectomy, which includes harvesting No. 12a lymph node (LN) station.

Aim

The purpose of this study was to identify the clinicopathologic factors associated with No. 12a lymph node metastasis. Methods and Results Eighty‐nine patients with GC undergoing gastrectomy and D2 lymphadenectomy were included in this single‐arm prospective cohort study. Logistic regression analyses were used to clarify the correlation between No. 12a involvement and clinicopathologic characteristics. Eighty‐nine patients (66% males) with a mean age of 58.86 ± 13.06 years were included. The upper third of the stomach was the most common tumor site (43.8%). neoadjuvant chemotherapy (NAC) was administered to 77 patients (86.5%). Total gastrectomy was the most common surgical procedure (67.4%), and 49.4% of tumors were poorly differentiated. Ten patients (11.24%) had 12a LN metastasis. Patients with 12a LN involvement exhibited greater number of harvested LNs in other stations (28.5[27–39.25] vs. 25[21–30], p = 0.024) and a higher presence of LN involvement in other stations (22[11–32] vs. 0[0–4], p = < 0.001). Univariate logistic regression analysis showed that the number of harvested other nodes (OR: 1.11[1.02–1.21]), number of involved other nodes (1.23[1.11–1.37]), omental involvement (OR: 10.86[1.84–64.24.57]), lymphovascular invasion (6.90[1.37–34.70]), and perineuronal invasion (OR: 6.16[1.23–31.11]) were significantly associated with No. 12a station metastasis. However, in multivariate logistic regression, only the number of involved other nodes showed a significant association with No. 12a station metastasis (OR: 1.30[1.09–1.55]). There was no difference between patients who received NAC and who did not in terms of No. 12a involvement ( p value = 0.61).

Conclusion

Among clinicopathologic risk factors, involvement of other lymph node stations was significantly associated with No. 12a lymph node metastasis. Therefore, No. 12a lymph node dissection should be considered in patients with advanced gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsGastrectomyLymph Node ExcisionLymph NodesHumansMaleFemaleMiddle AgedLymphatic MetastasisProspective StudiesAgedNeoadjuvant TherapyAdultPrognosisNeoplasm Staging

Stichwörter der Autor:innen

gastric cancerlymph node excisionlymph node metastasis

Autor:innen und Institutionen

  • Department of Surgery, Subdivision of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Amirmohsen Jalaeefar, Habibollah Mahmoodzadeh, Mohammad Shirkhoda, Ramesh Omranipour, Seyed Rouhollah Miri, Narjes Mohammadzadeh, Arshia Zardoui, Amirsina Sharifi

Zitieren

APA

Jalaeefar, A., Mahmoodzadeh, H., Shirkhoda, M., Omranipour, R., Miri, S. R., Mohammadzadeh, N., Zardoui, A., & Sharifi, A. (2025). Clinicopathological Factors Predisposing to No. 12a Lymph Node Metastasis in Gastric Cancer: A Prospective Cohort Analysis. Cancer Reports. https://doi.org/10.1002/cnr2.70239

Vancouver

Jalaeefar A, Mahmoodzadeh H, Shirkhoda M, Omranipour R, Miri SR, Mohammadzadeh N, et al. Clinicopathological Factors Predisposing to No. 12a Lymph Node Metastasis in Gastric Cancer: A Prospective Cohort Analysis. Cancer Reports. 2025. doi:10.1002/cnr2.70239

BibTeX
@article{Jalaeefar2025,
  author = {Jalaeefar, Amirmohsen and Mahmoodzadeh, Habibollah and Shirkhoda, Mohammad and Omranipour, Ramesh and Miri, Seyed Rouhollah and Mohammadzadeh, Narjes and Zardoui, Arshia and Sharifi, Amirsina},
  title = {Clinicopathological Factors Predisposing to No. 12a Lymph Node Metastasis in Gastric Cancer: A Prospective Cohort Analysis},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70239}
}
Kostenlos starten →